Motus Therapeutics
Motus is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases.
- Year invested 2010
- Investment Stage Early
- Sectors
- Investment Status Historic
- Associated Team
- Website motustx.com/
- Company Status Acquired (by Allergan)